2017 AHA/ACC/HRS Guideline for Management of Patients …

ure, non-ischaemic cardiomyopathy, valvular heart disease, pulmonary hypertension (PH), athletes’ hearts, congenital heart disease (CHD), and heart transplantation.3,4 Due to the growing body of evidence supporting the use of SE beyond the evaluation of ischaemia, its increasing implementation in many echocardiography laboratories ................
................